Background Image
Table of Contents Table of Contents
Previous Page  59 / 78 Next Page
Information
Show Menu
Previous Page 59 / 78 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 6, November/December 2017

AFRICA

397

Review Article

The effect of lifestyle interventions on maternal body

composition during pregnancy in developing countries:

a systematic review

Estelle D Watson, Shelley Macaulay, Kim Lamont, Philippe J-L Gradidge, Sandra Pretorius, Nigel J

Crowther, Elena Libhaber 

Abstract

Optimal maternal body composition during pregnancy is

a public health priority due to its implications on mater-

nal health and infant development. We therefore aimed to

conduct a systematic review of randomised, controlled trials,

and case–control and cohort studies using lifestyle interven-

tions to improve body composition in developing countries.

Of the

1 708 articles that were searched, seven studies, repre-

senting three countries (Brazil, Iran and Argentina), were

included in the review. Two articles suggested that interven-

tion with physical activity during pregnancy may significantly

reduce maternal weight gain, and five studies were scored

as being of poor quality. This systematic review highlights

the lack of research within developing countries on lifestyle

interventions for the management of excessive weight gain

during pregnancy. Similar reviews from developed countries

demonstrate the efficacy of such interventions, which should

be confirmed using well-designed studies with appropriate

intervention methods in resource-limited environments.

Keywords:

diet, physical activity, pregnancy, obesity, gestational

weight gain

Submitted 29/9/16, accepted 2/1/17

Published online 24/8/17

Cardiovasc J Afr

2017;

28

: 397–403

www.cvja.co.za

DOI: 10.5830/CVJA-2017-003

Both developed and developing countries are experiencing a

rapid increase in the prevalence of obesity, which places affected

individuals at an increased risk for a number of different

diseases, including hypertension, diabetes, heart disease, asthma

and cancer.

1,2

The World Health Organisation (WHO) estimated

that in 2005 there were approximately 1.6 billion adults (aged 15

years and over) globally who were overweight and at least 400

million adults who were obese.

3

Especially alarming is the high prevalence of overweight and

obesity among women of childbearing age in both developed

and developing countries. Around 12 to 38% of pregnant

women in developed countries,

5

and 8 to 26% of pregnant

women in developing countries

4,6

are reported to be overweight

or obese.

Obesity during pregnancy is associated with an increased risk

for maternal and neonatal complications. The associated adverse

maternal effects of obesity during pregnancy include miscarriage,

pre-eclampsia, gestational diabetes mellitus, infection, venous

thromboembolism and haemorrhage.

7

The foetal risks associated

with maternal obesity include stillbirths and neonatal deaths,

preterm births, congenital abnormalities and macrosomia.

8

Long-term effects of maternal obesity on the offspring have

also been observed and include increased risks of childhood and

adolescent obesity, and diabetes and cardiovascular disease in

adult life.

9

Centre for Exercise Science and Sports Medicine, School

of Therapeutic Sciences, Faculty of Health Sciences,

University of the Witwatersrand, Johannesburg, South Africa

Estelle D Watson, PhD,

estelle.watson@wits.ac.za

Philippe J-L Gradidge, PhD, MSc (Med)

MRC/Wits Developmental Pathways of Health Research

Unit, Department of Paediatrics, School of Clinical

Medicine, Faculty of Health Sciences, University of the

Witwatersrand, Johannesburg, South Africa

Estelle D Watson, PhD

Shelley Macaulay, MSc (Med) (Human Genetics), MSc (Med)

(Genetic Couselling), BSc (Hons)

Division of Human Genetics, School of Pathology, Faculty

of Health Sciences, University of the Witwatersrand and

the National Health Laboratory Service, Johannesburg,

South Africa

Shelley Macaulay, MSc (Med) (Human Genetics), MSc (Med)

(Genetic Couselling), BSc (Hons)

Soweto Cardiovascular Research Unit, University of the

Witwatersrand, Johannesburg, South Africa

Kim Lamont, PhD, MSc (Med), MPhil (Med) (IP Law)

Sandra Pretorius, PhD

Department of Chemical Pathology, National Heath

Laboratory Service, Faculty of Health Sciences, University

of the Witwatersrand, Johannesburg, South Africa

Nigel J Crowther, PhD

School of Clinical Medicine, Faculty of Health Sciences,

University of the Witwatersrand, Johannesburg, South Africa

Elena Libhaber, PhD